South Africans are not under any increased threat, despite a shortage of anti-venom for some of the continent's deadliest snakebites.
This is according to, expert herpetologist and CEO of the African Snakebite Institute, Johan Marais.
The antidote, known as FAV-Afrique, has been widely used by medical practitioners in Sub-Saharan Africa to treat snakebite victims.
However, Marais explains that South Africa relies on its own kind of anti-venom which is produced specifically for our most poisonous snakes such as the Boomslang.
We have the South African vaccine producer that make an effective anti-venom, and that's largely what is used in the country.— Johan Marais, CEO of the African Snakebite Institute
In other cases, a blended poly-venom is used to treat bites from any other deadly snakes.
He explains that the discontinued FAV-Afrique product was largely suited for West African countries and other parts of the continent with more deadly cases.
According to Marais, anti-venom is an urgent need in North Africa where snake bite deaths are more prevalent and vaccines more expensive.
Listen to the full conversation from CapeTalk's Breakfast with Kieno Kammies: